JP2016509471A - バイオマーカーの検出および収集のための方法およびデバイス - Google Patents

バイオマーカーの検出および収集のための方法およびデバイス Download PDF

Info

Publication number
JP2016509471A
JP2016509471A JP2015548022A JP2015548022A JP2016509471A JP 2016509471 A JP2016509471 A JP 2016509471A JP 2015548022 A JP2015548022 A JP 2015548022A JP 2015548022 A JP2015548022 A JP 2015548022A JP 2016509471 A JP2016509471 A JP 2016509471A
Authority
JP
Japan
Prior art keywords
probes
probe
biomarker
microneedle
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015548022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509471A5 (https=
Inventor
タヒル エー． マフムード，
タヒル エー． マフムード，
トビン ジェイ． ディッカーソン，
トビン ジェイ． ディッカーソン，
ナディル エー． マフムード，
ナディル エー． マフムード，
ペテル チャペック，
ペテル チャペック，
Original Assignee
マインデラ コーポレイション
マインデラ コーポレイション
ザ スクリプス リサーチ インスティテュート
ザ スクリプス リサーチ インスティテュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マインデラ コーポレイション, マインデラ コーポレイション, ザ スクリプス リサーチ インスティテュート, ザ スクリプス リサーチ インスティテュート filed Critical マインデラ コーポレイション
Publication of JP2016509471A publication Critical patent/JP2016509471A/ja
Publication of JP2016509471A5 publication Critical patent/JP2016509471A5/ja
Priority to JP2019162715A priority Critical patent/JP7572774B2/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150977—Arrays of piercing elements for simultaneous piercing
    • A61B5/150984—Microneedles or microblades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/04—Devices for withdrawing samples in the solid state, e.g. by cutting
    • G01N1/08—Devices for withdrawing samples in the solid state, e.g. by cutting involving an extracting tool, e.g. core bit
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B2010/008—Interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04—Arrangements of multiple sensors of the same type
    • A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/685—Microneedles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2543/00—Reactions characterised by the reaction site, e.g. cell or chromosome
    • C12Q2543/10—Reactions characterised by the reaction site, e.g. cell or chromosome the purpose being "in situ" analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
JP2015548022A 2012-12-14 2013-12-13 バイオマーカーの検出および収集のための方法およびデバイス Withdrawn JP2016509471A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019162715A JP7572774B2 (ja) 2012-12-14 2019-09-06 バイオマーカーの検出および収集のための方法およびデバイス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261737237P 2012-12-14 2012-12-14
US61/737,237 2012-12-14
PCT/US2013/075187 WO2014093934A1 (en) 2012-12-14 2013-12-13 Methods and devices for detection and acquisition of biomarkers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019162715A Division JP7572774B2 (ja) 2012-12-14 2019-09-06 バイオマーカーの検出および収集のための方法およびデバイス

Publications (2)

Publication Number Publication Date
JP2016509471A true JP2016509471A (ja) 2016-03-31
JP2016509471A5 JP2016509471A5 (https=) 2017-02-02

Family

ID=50935018

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015548022A Withdrawn JP2016509471A (ja) 2012-12-14 2013-12-13 バイオマーカーの検出および収集のための方法およびデバイス
JP2019162715A Active JP7572774B2 (ja) 2012-12-14 2019-09-06 バイオマーカーの検出および収集のための方法およびデバイス
JP2022157858A Withdrawn JP2022177287A (ja) 2012-12-14 2022-09-30 バイオマーカーの検出および収集のための方法およびデバイス
JP2024039825A Active JP7704916B2 (ja) 2012-12-14 2024-03-14 バイオマーカーの検出および収集のための方法およびデバイス
JP2025108143A Pending JP2025138775A (ja) 2012-12-14 2025-06-26 バイオマーカーの検出および収集のための方法およびデバイス

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019162715A Active JP7572774B2 (ja) 2012-12-14 2019-09-06 バイオマーカーの検出および収集のための方法およびデバイス
JP2022157858A Withdrawn JP2022177287A (ja) 2012-12-14 2022-09-30 バイオマーカーの検出および収集のための方法およびデバイス
JP2024039825A Active JP7704916B2 (ja) 2012-12-14 2024-03-14 バイオマーカーの検出および収集のための方法およびデバイス
JP2025108143A Pending JP2025138775A (ja) 2012-12-14 2025-06-26 バイオマーカーの検出および収集のための方法およびデバイス

Country Status (8)

Country Link
US (3) US9540684B2 (https=)
EP (2) EP2931356B1 (https=)
JP (5) JP2016509471A (https=)
KR (4) KR20240091108A (https=)
CN (3) CN119655753A (https=)
AU (5) AU2013358890A1 (https=)
CA (1) CA2892587A1 (https=)
WO (1) WO2014093934A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6231252B1 (ja) * 2016-07-08 2017-11-15 花王株式会社 核酸試料の調製方法
JP2020504749A (ja) * 2016-12-28 2020-02-13 ネクスモス カンパニー リミテッドＮｅｘｍｏｓ Ｃｏ．，Ｌｔｄ． アプタマーでコーティングされたマイクロニードルベースの診断用皮膚パッチの製造方法及びそのパッチ
JP2022520165A (ja) * 2019-01-30 2022-03-29 ラファス カンパニー リミテッド マイクロニードルパッチを利用した最小浸湿的皮膚生体検査方法
JP2022554046A (ja) * 2020-08-10 2022-12-28 カティス バイオメディカル リサーチ センター マイクロニードルパッチを含む最小侵襲的皮膚状態の診断キット

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
WO2014093934A1 (en) 2012-12-14 2014-06-19 Mindera Corporation Methods and devices for detection and acquisition of biomarkers
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
CA2951514C (en) 2014-06-18 2025-09-09 Clear Gene, Inc. METHODS, COMPOSITIONS AND DEVICES FOR THE RAPID ANALYSIS OF BIOLOGICAL MARKERS
US10321858B2 (en) * 2014-08-18 2019-06-18 Proteadx, Inc. Apparatus and methods for transdermal sensing of analytes in interstitial fluid and associated data transmission systems
US20170335396A1 (en) 2014-11-05 2017-11-23 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
WO2017007271A1 (ko) * 2015-07-09 2017-01-12 주식회사 넥스모스 앱타머 코팅된 마이크로니들 기반 진단용 피부 패치
GB201517373D0 (en) * 2015-10-01 2015-11-18 Ge Healthcare Uk Ltd Micro-Needle Sampling Device And Use Thereof
CA3008273A1 (en) 2015-12-18 2017-06-22 Clear Gene, Inc. Methods, compositions, kits and devices for rapid analysis of biological markers
JP6930986B2 (ja) * 2016-03-02 2021-09-01 ジェイ・ピィ・サイエンティフィック・リミテッドＪｐ Ｓｃｉｅｎｔｉｆｉｃ Ｌｉｍｉｔｅｄ サンプルから成分を抽出するための方法および装置
JP2020522690A (ja) * 2017-06-02 2020-07-30 ベラサイト インコーポレイテッド 肺疾病の特定又はモニタリング方法及びシステム
US12275994B2 (en) 2017-06-22 2025-04-15 Clear Gene, Inc. Methods and compositions for the analysis of cancer biomarkers
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
DE102018103215B3 (de) 2018-02-13 2019-08-14 Gna Biosolutions Gmbh Verfahren und Vorrichtung zur Extraktion einer Nukleinsäure aus einer Probenflüssigkeit
CA3090785A1 (en) 2018-02-14 2019-08-22 John Daniel Dobak Iii Novel gene classifiers and uses thereof in non-melanoma skin cancers
CN109459569A (zh) * 2018-07-28 2019-03-12 南昌大学 一种免血样肿瘤早期监测的方法
KR102239272B1 (ko) * 2018-11-20 2021-04-12 부산대학교 산학협력단 마이크로니들, 이를 포함하는 패치 및 이의 제조 방법
KR102513569B1 (ko) * 2019-03-19 2023-03-24 한국생명공학연구원 전사 시스템 기반 고감도 센서
WO2021002984A1 (en) * 2019-05-30 2021-01-07 Massachusetts Institute Of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
WO2020251802A1 (en) * 2019-06-14 2020-12-17 Bio-Rad Laboratories, Inc. System and method for automated single cell processing and analyses
NL2024277B1 (en) * 2019-11-21 2021-08-11 Imcomet B V Interstitial fluid removal device
KR102122208B1 (ko) * 2020-04-07 2020-06-12 주식회사 라파스 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트
JP2023523952A (ja) 2020-04-28 2023-06-08 ティコナ・エルエルシー マイクロニードルアセンブリ
US20210380965A1 (en) * 2020-06-08 2021-12-09 North Carolina State University Microneedle-based rapid analyte extraction from plant and animal tissues and related methods and systems
US20230310633A1 (en) * 2020-06-26 2023-10-05 Allymab, Inc. Binding modulator
CN116782827A (zh) * 2020-11-30 2023-09-19 明德拉公司 微针装置和方法以及皮肤病状测定
AU2021390587A1 (en) * 2020-12-04 2023-03-30 Dermr Health Solutions Pty Ltd Minimally invasive skin sample collection apparatus
KR102836680B1 (ko) * 2021-01-26 2025-07-21 단국대학교 천안캠퍼스 산학협력단 진단 및 분석을 위한 마이크로니들 기반 통합 액체생검 마이크로 시스템
CN113985034A (zh) * 2021-10-28 2022-01-28 赵超超 一种编码微针贴片及其制备方法和应用
CN114113024B (zh) * 2021-12-20 2023-07-07 深圳大学 一种检测乳腺癌组织间隙液中标志物的微针及其制备方法
WO2023192004A2 (en) * 2022-03-30 2023-10-05 Inflammatix, Inc. Methods for diagnosing myocardial infarction
CN116497121B (zh) * 2023-04-23 2025-06-27 陕西创悦熙妍企业管理有限公司 一种基因检测试剂盒及其应用
KR102856481B1 (ko) * 2023-11-08 2025-09-09 경북대학교 산학협력단 자성 교반 소자를 이용한 마이크로니들 자동화 분석 장치 및 그 방법
WO2025105915A1 (ko) * 2023-11-13 2025-05-22 (주)시지바이오 마이크로니들 구조체 및 이의 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036710A1 (en) * 2001-08-20 2003-02-20 Matriano James A. Method for transdermal nucleic acid sampling
US20030211528A1 (en) * 2002-03-12 2003-11-13 Norman Iscove Exponential amplification of sub-picogram nucleic acid samples with retention of quantitative representation
US20100178651A1 (en) * 2006-11-03 2010-07-15 Christos Hatzis Bifunctional Predictors of Cancer Treatment Sensitivity and Resistance
US20110160069A1 (en) * 2008-05-23 2011-06-30 The University Of Queensland Analyte detection using a needle projection patch

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6293925B1 (en) 1997-12-31 2001-09-25 Minimed Inc. Insertion device for an insertion set and method of using the same
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
AU6123899A (en) 1998-10-15 2000-05-01 Toyo Kohan Co. Ltd. Supports for immobilizing dna or the like
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6511463B1 (en) 1999-11-18 2003-01-28 Jds Uniphase Corporation Methods of fabricating microneedle arrays using sacrificial molds
US6692965B1 (en) * 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
ES2253278T3 (es) 1999-12-10 2006-06-01 Alza Corporation Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
MXPA02005765A (es) 1999-12-10 2003-01-28 Alza Corp Aparato de tratamiento de piel para el suministro de farmaco transdermico sostenido.
EP1127576A1 (de) * 2000-02-23 2001-08-29 Switch Biotech Aktiengesellschaft Verwendungen von NM23-Polypeptiden bei Haut- und Darmerkrankungen
KR100704528B1 (ko) 2000-04-04 2007-04-10 도요 고한 가부시키가이샤 표면 처리층이 형성된 슬라이드 글라스
US7078172B1 (en) 2000-08-08 2006-07-18 Toyo Kohan Co., Ltd. Substrate activation kit and method for detecting DNA and the like using the same
US6533949B1 (en) 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
PL360978A1 (en) 2000-10-13 2004-09-20 Alza Corporation Microblade array impact applicator
ATE416692T1 (de) 2000-10-13 2008-12-15 Alza Corp Mikronadelelementhalter für schlagapplikator
JP3605039B2 (ja) * 2001-01-09 2004-12-22 株式会社日立製作所 核酸マイクロアレイ、その製造方法及びそれを用いた核酸検出方法
WO2002072889A2 (en) * 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2003016574A1 (en) * 2001-08-16 2003-02-27 Zhifeng Shao Analysis of gene expression profiles using sequential hybridization
US6881203B2 (en) 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
AU2002343457A1 (en) 2001-09-28 2003-04-07 Biovalve Technologies, Inc. Switchable microneedle arrays and systems and methods relating to same
AU2012213965B2 (en) * 2003-09-11 2015-10-22 Labrador Diagnostics Llc Medical device for analyte monitoring and drug delivery
WO2005052001A2 (en) * 2003-11-21 2005-06-09 Zymogenetics, Inc. Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation
US8551391B2 (en) 2004-02-17 2013-10-08 Avery Dennison Corporation Method of making microneedles
JP4202391B2 (ja) * 2004-03-17 2008-12-24 パナソニック株式会社 バイオチップの製造方法、プローブ溶液、および、バイオチップ
DK2995331T3 (da) 2004-09-10 2019-01-02 Becton Dickinson Co Rekonstitutonsinfusionsindretning og fremgangsmåde til rekostituering af et medikament
WO2006042328A2 (en) * 2004-10-12 2006-04-20 John Wayne Cancer Institute Treatment of cancer and compositions
TW200730825A (en) * 2005-10-21 2007-08-16 Genenews Inc Method and apparatus for correlating levels of biomarker products with disease
US8007999B2 (en) * 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
WO2007143669A2 (en) * 2006-06-05 2007-12-13 California Institute Of Technology Real time micro arrays
EP2041574B1 (en) * 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof
EP2119469B1 (en) 2007-02-06 2014-05-14 Hisamitsu Pharmaceutical Co., Inc. Microneedle device for diagnosis of allergy
EP2130913A4 (en) 2007-03-05 2010-09-01 On Chip Cellomics Consortium CHIP FOR CELL COMPONENT SAMPLING, CELL COMPONENT ANALYSIS SYSTEM AND CELL COMPONENT ANALYSIS METHOD USING THEREOF
CA2686861A1 (en) * 2007-05-03 2008-11-13 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
EP2160472A1 (en) * 2007-06-04 2010-03-10 IN Situ RCP A/S Enzyme activity assay using rolling circle amplification
US8609041B2 (en) 2007-08-06 2013-12-17 Samir Mitragotri Apparatus for solubilizing tissue
WO2009023517A2 (en) 2007-08-10 2009-02-19 Wayne State University Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
KR101555391B1 (ko) 2007-11-21 2015-09-23 가부시키가이샤 바이오세렌택 체표 적용 제제 및 체표 적용 제제 보유 시트
WO2010031059A2 (en) 2008-09-15 2010-03-18 Deka Products Limited Partnership Systems and methods for fluid delivery
US8613937B2 (en) 2008-10-31 2013-12-24 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
WO2010101625A2 (en) 2009-03-02 2010-09-10 Seventh Sense Biosystems, Inc. Oxygen sensor
WO2010128158A1 (en) 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
EP2275164A1 (en) 2009-07-15 2011-01-19 Debiotech S.A. Multichannel micro-needles
RU2570280C2 (ru) 2010-04-28 2015-12-10 Кимберли-Кларк Ворлдвайд, Инк. Композитная матрица микроигл, содержащая на поверхности наноструктуры
US20110294996A1 (en) * 2010-05-31 2011-12-01 Scheiber Lane Bernard Quantum unit of inheritance
CN103261413B (zh) 2010-12-03 2015-09-16 株式会社益力多本社 三剂并用抗癌剂感受性判定标记
WO2014093934A1 (en) 2012-12-14 2014-06-19 Mindera Corporation Methods and devices for detection and acquisition of biomarkers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036710A1 (en) * 2001-08-20 2003-02-20 Matriano James A. Method for transdermal nucleic acid sampling
US20030211528A1 (en) * 2002-03-12 2003-11-13 Norman Iscove Exponential amplification of sub-picogram nucleic acid samples with retention of quantitative representation
US20100178651A1 (en) * 2006-11-03 2010-07-15 Christos Hatzis Bifunctional Predictors of Cancer Treatment Sensitivity and Resistance
US20110160069A1 (en) * 2008-05-23 2011-06-30 The University Of Queensland Analyte detection using a needle projection patch

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6231252B1 (ja) * 2016-07-08 2017-11-15 花王株式会社 核酸試料の調製方法
JP2018000206A (ja) * 2016-07-08 2018-01-11 花王株式会社 核酸試料の調製方法
WO2018008319A1 (ja) * 2016-07-08 2018-01-11 花王株式会社 核酸試料の調製方法
US11913061B2 (en) 2016-07-08 2024-02-27 Kao Corporation Method for preparing nucleic acid sample
JP2020504749A (ja) * 2016-12-28 2020-02-13 ネクスモス カンパニー リミテッドＮｅｘｍｏｓ Ｃｏ．，Ｌｔｄ． アプタマーでコーティングされたマイクロニードルベースの診断用皮膚パッチの製造方法及びそのパッチ
JP2022520165A (ja) * 2019-01-30 2022-03-29 ラファス カンパニー リミテッド マイクロニードルパッチを利用した最小浸湿的皮膚生体検査方法
JP7272711B2 (ja) 2019-01-30 2023-05-12 ラファス カンパニー リミテッド マイクロニードルパッチを利用した最小浸湿的皮膚生体検査方法
JP2022554046A (ja) * 2020-08-10 2022-12-28 カティス バイオメディカル リサーチ センター マイクロニードルパッチを含む最小侵襲的皮膚状態の診断キット
JP7807811B2 (ja) 2020-08-10 2026-01-28 カティス バイオメディカル リサーチ センター マイクロニードルパッチを含む最小侵襲的皮膚状態の診断キット

Also Published As

Publication number Publication date
WO2014093934A1 (en) 2014-06-19
JP7572774B2 (ja) 2024-10-24
JP2022177287A (ja) 2022-11-30
JP2025138775A (ja) 2025-09-25
AU2023204575B2 (en) 2025-07-10
KR102216949B1 (ko) 2021-02-22
HK1212932A1 (en) 2016-06-24
JP2024073562A (ja) 2024-05-29
CN119655753A (zh) 2025-03-21
KR20210020164A (ko) 2021-02-23
KR102378235B1 (ko) 2022-03-25
EP3542850A1 (en) 2019-09-25
AU2023204575A1 (en) 2023-08-03
JP2019216746A (ja) 2019-12-26
KR20240091108A (ko) 2024-06-21
CA2892587A1 (en) 2014-06-19
CN104853802A (zh) 2015-08-19
AU2025248690A1 (en) 2025-10-30
AU2020239750B2 (en) 2023-04-20
US9540684B2 (en) 2017-01-10
CN104853802B (zh) 2021-12-07
AU2019201136A1 (en) 2019-03-07
EP2931356B1 (en) 2019-03-06
KR20220038832A (ko) 2022-03-29
EP2931356A1 (en) 2015-10-21
CN114176586B (zh) 2025-01-07
KR20150123788A (ko) 2015-11-04
US20170145489A1 (en) 2017-05-25
US20210317513A1 (en) 2021-10-14
US10995366B2 (en) 2021-05-04
US20140287942A1 (en) 2014-09-25
AU2019201136B2 (en) 2020-06-25
AU2013358890A1 (en) 2015-06-04
JP7704916B2 (ja) 2025-07-08
CN114176586A (zh) 2022-03-15
EP2931356A4 (en) 2016-08-24
AU2020239750A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
JP7704916B2 (ja) バイオマーカーの検出および収集のための方法およびデバイス
JP5453534B2 (ja) 多重スポット金属蒸着型ナノ構造配列角膜ジストロフィー診断用核酸チップ及びこの製造方法
TWI680296B (zh) 用於檢測胰腺癌的基因標誌物、試劑組及胰腺癌檢測方法
JP2009543552A5 (https=)
ES2527062T3 (es) Supervivencia y recurrencia del cáncer de próstata
Qi et al. Ultrasensitive point-of-care detection of protein markers using an aptamer-CRISPR/Cas12a-regulated liquid crystal sensor (ALICS)
HK40014889A (en) Methods and devices for detection and acquisition of biomarkers
HK1212932B (en) Methods and devices for detection and acquisition of biomarkers
Applegate Molecular monitoring of acute promyelocytic leukaemia using novel DzyNA technology.
KR20200020160A (ko) 타액 프로토콜
CN112135913A (zh) 使用等温核酸扩增对生物组织三维核酸成像诊断的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150813

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161213

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171024

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171031

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191007

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20191028

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20191031